Transmission and emission images obtained in the TGS assays will be presented.
Finally, a comparison of cell-based binding assays to other types of binding assays will be presented.
We believe the use of OSR DNA to be a valid substitute since none of the primer sequences for either assay will be present in non-transgenic soya or oilseed rape.
Three μg total RNA were kept for transcriptome analyses, 1 μg for RT-qPCR and 500 ng for the FASAY assay to detect p53 mutations (data will be presented in a separate paper).
More specifically, modes of action for identified classes of chitinases, experimental assays, and prospects for metabolic engineering targets of chitin degradation products will be presented.
The need to integrate chromosome aberration and the challenge assays with other relevant assays for better documentation of biological effects and for more precise prediction of health risk will be presented.
The influence of consistency of assay setups can directly be quantified via the variability and practical consequences for MMP analysis will be presented.
Afternoons water shows will be presented.
The Oscars will be presented 24 February.
Some screenings will be presented elsewhere.
